PHR logo

PHREESIA INC

PHRNYSE
๐Ÿ† #2594 by market capEarnings Sep 2US Equity
$12.26โ–ผ $0.01 (โˆ’0.08%)
๐ŸŒ™ After hours$12.26โ–ฒ 0.00%Regular close ยท extended-hours price shown
1hโ–ฒ 0.0%
24hโ–ผ 0.1%
7dโ–ฒ 6.7%
14dโ–ฒ 10.1%
30dโ–ฒ 11.2%
1yโ–ผ 56.0%
๐ŸฆMarket Cap
$758M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+14.1%
Healthy
๐Ÿ“ŠGross Margin
67.8%
High
๐Ÿ’ตFCF Margin
12.8%
Healthy
โš–๏ธP/S Ratio
1.5x
Cheap
Otter Score
43
Weak

Trading Snapshot

Day Range
$12.18 โ€“ $12.49
52-Week Range
$7.77 โ€“ $32.76
Volume
$1.64B
Avg Volume
$1.88B
Shares Outstanding
61.8M
Next Earnings
Oct 14, 2026

Fundamentals Snapshot

Annual Revenue
$481M
Last Q Revenue
$131M
P/E Ratio
83.3
P/S Ratio
1.5x
EPS (TTM)
$0.15
Dividend Yield
โ€”

Why Investors Own PHR

  • โœ“High-growth profile โ€” revenue up +36.2% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 63% gross margin and 7% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$481Mโ–ฒ +42.5% YoY
Gross Margin (TTM)
63.4%โ–ฒ +4.1% YoY
Operating Income (TTM)
$46Mโ–ฒ +42.5% YoY
Free Cash Flow (TTM)
$35Mโ–ฒ +42.5% YoY

About PHREESIA INC

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
43/100

Analyst Ratings

โ“˜
Consensus
Buy
23 analysts
Strong Buy3
Buy11
Hold9
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates

Yahooยท6d ago

Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results

ALL-REMOTE COMPANY/WILMINGTON, Del., August 06, 2026--Phreesia will release its fiscal second quarter 2027 financial results after the close of market trading on Wednesday, Sept. 2, 2026.

Yahooยท6d ago

Enovis (ENOV) Beats Q2 Earnings and Revenue Estimates

Enovis (ENOV) delivered earnings and revenue surprises of +8.43% and +0.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Yahooยท6d ago

Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates

Schrodinger (SDGR) delivered earnings and revenue surprises of +113.33% and +15.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Yahooยท20d ago

Phreesia and March of Dimes Partner to Help Strengthen Physician-Patient Conversations and Improve the Health of Moms and Babies

ALL-REMOTE COMPANY/WILMINGTON, Del., July 23, 2026--Phreesia and March of Dimes announce a partnership to enhance critical physician-patient conversations during prenatal and postpartum appointments.

Yahooยท22d ago

Should Value Investors Buy Phreesia (PHR) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Yahooยท22d ago

MediFind Launches AI-Powered Chatbot to Help Patients Find and Book the Right Provider

ALL-REMOTE COMPANY/WILMINGTON, Del., July 21, 2026--MediFind, a data-powered online provider directory offered by Phreesia, is announcing the launch of Chloe, its new "Find the Right Provider" chatbot.